US Patent 11753458 CTLA-4 variant immunomodulatory proteins and uses thereof
Patent 11753458 was granted and assigned to ALPINE IMMUNE SCIENCES, INC. on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+86 properties)
Article (+356 characters)
US Patent 11753458 CTLA-4 variant immunomodulatory proteins and uses thereof
Article
Provided herein are variant CTLA-4 polypeptides and immunomodulatory proteins and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of disease applications, including for treatment of autoimmune or inflammatory conditions. Compositions and methods for making and using such proteins are provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11753458
Patent Inventor Names
Joseph L. Kuijper
Lawrence Evans
Ryan Swanson
Date of Patent
September 12, 2023
Patent Application Number
16755072
Date Filed
October 9, 2018
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11753458 CTLA-4 variant immunomodulatory proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
